Daily News Podcast

Cardiovascular risk with diclofenac


 

Diclofenac has emerged as a clear culprit in higher risk for adverse cardiovascular events. Also today, the majority of e-cigarette users are under 35 years of age, a hospital dropped length of stay for neonatal abstinence syndrome, and physician groups continue to call for CMS to drop evaluation and management proposal.
Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Screen for cervical cancer based on age, risk
MDedge Dermatology
Is it time for PCPs to take over chronic HCV?
MDedge Dermatology
Rivaroxaban data abound at ESC 2018
MDedge Dermatology
New MI definition for infarction vs injury
MDedge Dermatology
Lorcaserin shows cardiovascular safety
MDedge Dermatology
Lung function decline linked to cardiovascular risk
MDedge Dermatology
Product News: 09 2018
MDedge Dermatology
Rivaroxaban beats aspirin for VTE
MDedge Dermatology
FDA approval for 2 HIV drugs
MDedge Dermatology
Modest alcohol and NAFLD
MDedge Dermatology